Anika to Showcase Joint Preservation & Restoration Portfolio at the Annual Scientific Meeting of the International Society fo...
October 16 2019 - 8:30AM
Business Wire
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated
joint preservation and regenerative therapies company with products
leveraging its proprietary hyaluronic acid ("HA") technology
platform, today announced plans to showcase its osteoarthritis pain
management and joint preservation and restoration regenerative
therapies at the Annual Scientific Meeting of the International
Society for Hip Arthroscopy (ISHA). The ISHA Annual Scientific
Meeting is being held October 17-19, 2019 in Madrid, Spain, and it
provides a unique international forum for attendees to share
scientific information and learn the latest advancements of
arthroscopic surgery of the hip. The meeting is expected to be
attended by over 500 medical professionals from over 35
countries.
“Anika has a versatile HA technology platform with the potential
to expand its product portfolio into new indications to drive
sustained growth and value for patients and shareholders,” said
Joseph Darling, President and CEO, Anika Therapeutics. “We look
forward to engaging with hip specialists at this year’s ISHA
Scientific Meeting, as we focus on broadening our solutions across
the joint preservation and restoration continuum of care.”
The company will showcase its CINGAL and HYALOFAST therapies at
booth #18.
About ISHA
The ISHA (International Society for Hip Arthroscopy) is an
orthopedic society focused on hip preservation founded by
individuals united by a common interest in the expanding arena of
hip arthroscopic surgery. Officially formed in Paris, France in May
2008, ISHA’s founding members represent but a few of the many
individuals around the world who are interested in this evolving
area of hip surgery. At its outset, hip arthroscopy attracted the
surgical and scientific innovator, the clinician with an eye for
the unusual idea. Instrumentation was often handmade and company
support was lacking. Now, training courses around the world are
frequently oversubscribed, peer-reviewed publications are
increasing in number and hip arthroscopic surgery is well
established. ISHA’s role is to provide a focal point for its
further development, to be a society whose vision is to be the
premier international society for education and research in
arthroscopic hip surgery.
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (NASDAQ: ANIK) is a global,
integrated joint preservation and regenerative therapies company
based in Bedford, Massachusetts. Anika is committed to delivering
therapies to improve the lives of patients across a continuum of
care from osteoarthritis pain management to joint preservation and
restoration. The Company has over two decades of global expertise
commercializing more than 20 products based on its proprietary
hyaluronic acid (HA) technology platform. For more
information about Anika, please visit
www.anikatherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191016005085/en/
For Investor Inquiries: Anika Therapeutics, Inc. Sylvia Cheung,
781-457-9000 Chief Financial Officer
For Media Inquiries: W2O Group Sonal Vasudev, 917-523-1418
sonal@w2ogroup.com
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Apr 2023 to Apr 2024